• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种不健康的公私紧张关系:菲律宾的药房所有权、处方和支出。

An unhealthy public-private tension: pharmacy ownership, prescribing, and spending in the Philippines.

机构信息

London School of Hygiene and Tropical Medicine, United Kingdom.

出版信息

Health Aff (Millwood). 2009 Jul-Aug;28(4):1022-33. doi: 10.1377/hlthaff.28.4.1022.

DOI:10.1377/hlthaff.28.4.1022
PMID:19597201
Abstract

Physicians' links with pharmacies may create perverse financial incentives to overprescribe, prescribe products with higher profit margins, and direct patients to their pharmacy. Interviews with pharmacy customers in the Philippines show that those who use pharmacies linked to public-sector physicians had 5.4 greater odds of having a prescription from such physicians and spent 49.3 percent more than customers using other pharmacies. For customers purchasing brand-name medicines, switching to generics would reduce drug spending by 58 percent. Controlling out-of-pocket spending on drugs requires policies to control financial links between doctors and pharmacies, as well as tighter regulation of nongeneric prescribing.

摘要

医生与药店的关系可能会产生不正当的财务激励,导致过度开药、开利润更高的产品,并引导患者到他们的药店。对菲律宾药店顾客的采访表明,那些使用与公共部门医生有关联的药店的人,从这些医生那里获得处方的可能性要高出 5.4 倍,花费也要高出 49.3%。对于购买品牌药的顾客来说,改用仿制药将使药品支出减少 58%。控制药品自付支出需要有政策来控制医生和药店之间的财务联系,并加强对非仿制药处方的监管。

相似文献

1
An unhealthy public-private tension: pharmacy ownership, prescribing, and spending in the Philippines.一种不健康的公私紧张关系:菲律宾的药房所有权、处方和支出。
Health Aff (Millwood). 2009 Jul-Aug;28(4):1022-33. doi: 10.1377/hlthaff.28.4.1022.
2
Ethical prescribing.道德处方
Health Aff (Millwood). 2009 Nov-Dec;28(6):1861-2; author reply 1862. doi: 10.1377/hlthaff.28.6.1861-a.
3
Changing physician prescribing behavior: a low-cost administrative policy that reduced the use of brand name nonsteroidal anti-inflammatory drugs.
Prev Med. 1996 Nov-Dec;25(6):668-72. doi: 10.1006/pmed.1996.0105.
4
Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan.财务激励与医生在品牌药和仿制药之间选择的处方决策:来自台湾的证据。
J Health Econ. 2009 Mar;28(2):341-9. doi: 10.1016/j.jhealeco.2008.10.009. Epub 2008 Nov 5.
5
Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals?私人医生是否更有可能否决处方药的通用名替换?
Soc Sci Med. 2009 Dec;69(11):1643-50. doi: 10.1016/j.socscimed.2009.09.016. Epub 2009 Oct 6.
6
Adverse pharmaceutical payment incentives and providers' behaviour: the emergence of GP-owned gateway pharmacies in Taiwan.药品支付激励措施的负面影响与医疗服务提供者的行为:台湾地区全科医生所有的前置药房的兴起
Health Policy Plan. 2007 Nov;22(6):427-35. doi: 10.1093/heapol/czm035. Epub 2007 Sep 26.
7
Generic medicines: Greek physicians' perceptions and prescribing practices.仿制药:希腊医生的认知与处方习惯。
J Clin Pharm Ther. 2009 Oct;34(5):547-54. doi: 10.1111/j.1365-2710.2009.01037.x.
8
Prudent prescribing. Prescribing suggestions for physicians.谨慎开药。给医生的开药建议。
N C Med J. 1992 Nov;53(11):585-8.
9
Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.探索仿制药使用行为:开处方者和药剂师在仿制药使用机会及仿制药替代中的作用。
Med Care. 2002 Aug;40(8):662-74. doi: 10.1097/01.MLR.0000020926.85284.8E.
10
Generics: what's in a name?通用名:名称里有什么?
Int J Fertil Womens Med. 1998 May-Jun;43(3):139-49.

引用本文的文献

1
Comparative effectiveness of two disparate policies on child health: experimental evidence from the Philippines.两项不同政策对儿童健康的比较效果:来自菲律宾的实验证据。
Health Policy Plan. 2017 May 1;32(4):563-571. doi: 10.1093/heapol/czw179.
2
Market size and sales pattern of tuberculosis drugs in the Philippines.菲律宾结核病药物的市场规模与销售模式。
Public Health Action. 2013 Dec 21;3(4):337-41. doi: 10.5588/pha.13.0094.
3
A structuration framework for bridging the macro-micro divide in health-care governance.一个用于弥合医疗保健治理中宏观与微观差距的结构化框架。
Health Expect. 2016 Aug;19(4):790-804. doi: 10.1111/hex.12375. Epub 2015 Jun 12.
4
Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries.来自五个低收入和中等收入国家家庭调查的慢性病药品可及性证据。
Health Policy Plan. 2015 Oct;30(8):1044-52. doi: 10.1093/heapol/czu107. Epub 2014 Sep 24.
5
Challenges of drug risk communications in the Philippines.菲律宾药品风险沟通面临的挑战。
Drug Saf. 2012 Nov 1;35(11):995-1004. doi: 10.1007/BF03261987.
6
Do doctors under-provide, over-provide or do both? Exploring the quality of medical treatment in the Philippines.医生是提供过少、过多还是两者都有?探讨菲律宾的医疗质量。
Int J Qual Health Care. 2011 Aug;23(4):445-55. doi: 10.1093/intqhc/mzr029. Epub 2011 Jun 13.